Statistics for Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.
Total visits
| views | |
|---|---|
| Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230. | 169 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 1 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| ClinInfectDis_A5230_Wk104.pdf | 144 |
Top country views
| views | |
|---|---|
| United Kingdom | 35 |
| Germany | 34 |
| United States | 15 |
| South Korea | 6 |
| China | 4 |
| Singapore | 3 |
| Italy | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Kiez | 22 |
| Alexandria | 10 |
| Seoul | 3 |
| Beijing | 2 |
| Changi | 2 |
| Ann Arbor | 1 |
| Brooklyn | 1 |
| Durham | 1 |
| Frankfurt Am Main | 1 |
| Guangzhou | 1 |
| Los Angeles | 1 |
| Norwalk | 1 |
| Oklahoma City | 1 |
| Podolsk | 1 |
| Singapore | 1 |
| Yulee | 1 |